[VRTX] YoY Quarter Result on 30-Sep-2012 [#Q3]

Stock
[VRTX] Vertex Pharmaceuticals Incorporated
Announcement Date
06-Nov-2012
Financial Year
2012
Quarter
30-Sep-2012 [#Q3]
Profit Trend
QoQ- 11.38%
YoY- -126.02%
Quarter Report
VRTX's Result
VRTX's Financial Summary
View:
Show?
Quarter Result
30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 CAGR
Revenue 309,816 178,987 221,700 336,006 659,200 23,795 24,957 52.13%
PBT -92,486 -166,577 -129,406 -5,112 200,610 -208,957 -149,565 -7.69%
Tax 1,330 3,419 -751 21,355 -27,842 3,477 -4,709 -
NP -95,149 -170,060 -124,125 -57,543 221,110 -208,957 -149,565 -7.25%
Tax Rate - - - - 13.88% - - -
Total Cost 404,965 349,047 345,825 393,549 438,090 232,752 174,522 15.05%
Ratio Analysis
30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 CAGR
NP Margin -30.71 -95.01 -55.99 -17.13 33.54 -878.16 -599.29 -39.04%
Per Share
30/09/15 30/09/14 30/09/13 30/09/12 30/09/11 30/09/10 30/09/09 CAGR
EPS -0.39 -0.72 -0.54 -0.27 1.06 -1.04 -0.84 -11.99%
EPS Diluted -0.39 -0.72 -0.54 -0.27 1.02 -1.04 -0.84 -11.99%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.